Grading of Hirsutism: A Practical Approach to the Modified Ferriman-Gallwey Scoring System

    October 2021 in “ Postepy Dermatologii I Alergologii
    Filiz Cebeci, Sevil Savaş Erdoğan
    Image of study
    TLDR Checking the chin, thighs, upper lip, or lower abdomen is enough to predict hirsutism.
    The study, involving 227 patients diagnosed with hirsutism and having modified Ferriman-Gallwey (mFG) scores of ≥ 8, aimed to simplify the mFG score to prevent overlooking hirsutism diagnoses and facilitate patient examinations during the pandemic. The results showed that terminal hair was present on the chin in 97.4% (n = 221), thighs in 96.5% (n = 219), upper lip in 94.7% (n = 215), and lower abdomen in 92.1% (n = 205) of the patients. Terminal hair growth scored as ≥ 1 was found in 89% of the patients (n = 202) for the combination of the chin, thighs, and upper lip, and in 87.2% (n =198) for the combination of the chin, thighs, and lower abdomen. The study concluded that examining the chin, thighs, upper lip, or lower abdomen can sufficiently predict hirsutism, providing a practical approach to the mFG scoring system during the pandemic.
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results

    Related Community Posts Join

    6 / 23 results

      community AA and Hirsutism but T levels are normal

      in Female  6 upvotes 3 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  118 upvotes 4 weeks ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Does low HGH leading to hairloss?

      in Research/Science  12 upvotes 8 months ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

      community Any balding females? I need advice with coping :(

       16 upvotes 8 years ago
      A 27-year-old woman is struggling with hair loss, feeling self-conscious and seeking advice on coping. She mentions trying Minoxidil but is hesitant due to scalp issues and is looking for ways to regain confidence.

    Related Research

    2 / 2 results